Robert A Copeland's Net Worth
$6.71 Million
Who is Robert A Copeland?
Robert A Copeland has an estimated net worth of $6.71 Million. This is based on reported shares in Epizyme, Inc..
SEC CIK
Robert A Copeland's CIK is 0001577021
Past Insider Trading and Trends
2014 was Robert A Copeland's most active year for acquiring shares with 11 total transactions. Robert A Copeland's most active month to acquire stocks was the month of May. 2014 was Robert A Copeland's most active year for disposing of shares, totalling 31 transactions. Robert A Copeland's most active month to dispose stocks was the month of May. 2016 saw Robert A Copeland paying a total of $138,723.87 for 165,923 shares, this is the most they've acquired in one year. In 2014 Robert A Copeland cashed out on 397,944 shares for a total of $5,916,867.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Epizyme, Inc. No price found
President Research and CSORobert A Copeland owns 31,538 units of Common Stock, par value $0.0001, 31,538 units of Commons Stock, par value $0.0001. Robert A Copeland used to own units in Common Stock, par value $0.0001 per share and Common Stock, part value $0.0001 per share but no longer holds any shares there. In the year 2013 Robert A Copeland filed a total of 34 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.49 | -$24,775.00 | 31.54K |
Scheduled
|
Jun 6
| ||
Form 4
|
—
|
0
|
$10.49 | -$69,512.50 | 31.54K |
Scheduled
|
May 2
| ||
Form 4
|
—
|
0
|
$9.68 | -$66,805.00 | 31.54K |
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
$6.28 | -$32,731.60 | 31.54K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$6.11 | -$31,367.60 |
0
|
Scheduled
|
Jul 5
| ||
Form 4
|
∞
| 31.54K |
$3.54 | $111,644.52 | 31.54K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
$8.93 | -$55,623.70 |
0
|
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$7.69 | -$51,352.21 |
0
|
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$8.43 | -$65,547.98 |
0
|
Scheduled
|
Nov 9
| ||
Form 4
|
—
|
0
|
$7.52 | -$57,868.92 | 4.18K |
Scheduled
|
Oct 5
| ||
Form 4
|
—
|
0
|
$10.09 | -$79,410.37 |
0
|
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$11.40 | -$180,704.95 |
0
|
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$11.73 | -$186,488.25 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
$12.44 | -$409,836.00 |
0
|
Scheduled
|
Nov 17
| ||
Form 4
|
—
|
0
|
$13.57 | -$476,171.72 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$13.75 | -$526,030.60 |
0
|
Scheduled
|
Oct 7
| ||
Form 4
|
—
|
0
|
$13.08 | -$498,990.00 |
0
|
Scheduled
|
Sep 22
| ||
Form 4
| -100.00% | -10.83K |
$36.07 | -$390,612.66 |
0
|
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
$15.01 | -$576,346.95 | 5.3K |
Scheduled
|
Aug 4
| ||
Form 4
|
—
|
0
|
$14.50 | -$557,001.65 | 5.3K |
Scheduled
|
Jun 23
| ||
Form 4
| -69.78% | -25.01K |
$26.38 | -$659,889.09 | 10.83K |
Scheduled
|
Jun 16
| ||
Form 4
|
—
|
0
|
$11.40 | -$836,481.44 | 17.56K |
Scheduled
|
Jun 2
| ||
Form 4
| -12.24% | -5.00K |
$22.28 | -$111,380.49 | 35.84K |
Scheduled
|
May 19
| ||
Form 4
| -19.67% | -10.00K |
$21.29 | -$212,884.00 | 40.84K |
Scheduled
|
May 5
| ||
Form 4
|
—
|
0
|
$10.62 | -$279,047.04 | 24.91K |
Scheduled
|
Apr 28
| ||
Form 4
| -43.50% | -19.18K |
$29.25 | -$560,985.75 | 24.91K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| -17.65% | -15.01K |
$39.27 | -$589,253.86 | 70.02K |
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
$11.70 | -$87,470.84 | 53.54K |
Scheduled
|
Dec 16
| ||
Form 4
| -5.55% | -5.00K |
$20.70 | -$103,482.00 | 85.03K |
Scheduled
|
Dec 2
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||